Harrison, James D <br/><br/>
Rising cancer antigen 125 level and the type and timing of treatment for recurrent ovarian cancer: a clinical dilemma, but what would women do?  [electronic resource] 

 -  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society  Aug 2009 
 - 1037-46 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-1438 
<br/><br/><label>Standard No.: </label>10.1111/IGC.0b013e3181a83d0b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Protocols<br/>Biomarkers, Tumor--blood<br/>CA-125 Antigen--blood<br/>Decision Making<br/>Female<br/>Humans<br/>Neoplasms, Glandular and Epithelial--blood<br/>Ovarian Neoplasms--blood<br/>Patient Education as Topic<br/>Patient Preference--psychology<br/>Recurrence<br/>Sentinel Surveillance<br/>Social Class<br/>Surveys and Questionnaires<br/>Time Factors<br/>Up-Regulation